Subcommittee Hearing Comes at a Critical Time
Read We Work For Health's statement in response to the U.S. House Ways and Means Subcommittee on Health hearing on policies that will have negative impact on medical innovation.
Lawmakers Should Focus on Solutions that Directly Support Affordability, Accessibility and Innovation
Read We Work For Health's statement in response to President Biden’s focus on the expansion of Medicare drug pricing negotiations in the administration’s proposed federal budget.
Fix the IRA Before its Unintended Consequences Harm Patients and Workers
Read We Work For Health's letter that was sent to the Biden Administration and the statement issued in response to the State of the Union address.
Working Together to Advance Health and Power Future Innovation One Pager and Q&A
Learn more about We Work For Health and how to get involved.
Congressional User Fees Agreement Marks a Step Forward for Patients and Innovators
Read We Work For Health's statement on the reauthorization of the Prescription Drug and Biosimilar User Fee Acts.
The Far-Reaching Health, Economic and Innovation Impact of Harmful Government Price Setting Policies
Read a statement from We Work For Health's Co-Chair, Tom Kowalski, on the harmful impact of government price setting policies.
A Blown Play: When Congress Treats Patients Like a Political Football, We all Lose
Read a statement from We Work For Health's Co-Chair, Rolf Benirschke.